Symic Bio Appoints Morten Karsdal, Ph.D., to Scientific Advisory Board

06:12 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
SAN FRANCISCO, Oct. 19, 2016 /PRNewswire/ -- Symic Bio, a clinical stage biopharmaceutical company developing a new category of therapeutics focused on extracellular matrix biology, today announced that Morten Karsdal, Ph.D., has been appointed as a m...

Other Sources for this Article


More From BioPortfolio on "Symic Bio Appoints Morten Karsdal, Ph.D., to Scientific Advisory Board"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...